1. Home
  2. BXP vs ICLR Comparison

BXP vs ICLR Comparison

Compare BXP & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Properties Inc.

BXP

Boston Properties Inc.

HOLD

Current Price

$63.36

Market Cap

11.1B

Sector

Real Estate

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$172.40

Market Cap

13.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXP
ICLR
Founded
1970
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
13.1B
IPO Year
2000
2001

Fundamental Metrics

Financial Performance
Metric
BXP
ICLR
Price
$63.36
$172.40
Analyst Decision
Buy
Buy
Analyst Count
18
13
Target Price
$71.94
★ $178.62
AVG Volume (30 Days)
★ 1.1M
883.9K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
★ 4.86%
N/A
EPS Growth
★ 1833.33
N/A
EPS
★ 1.07
N/A
Revenue
★ $3,482,279,000.00
N/A
Revenue This Year
$11.00
N/A
Revenue Next Year
$2.91
N/A
P/E Ratio
$58.20
★ $12.91
Revenue Growth
★ 2.19
N/A
52 Week Low
$49.93
$66.57
52 Week High
$76.37
$203.91

Technical Indicators

Market Signals
Indicator
BXP
ICLR
Relative Strength Index (RSI) 41.10 55.08
Support Level $62.69 $162.32
Resistance Level $67.10 $181.71
Average True Range (ATR) 1.38 6.52
MACD -0.14 0.48
Stochastic Oscillator 28.10 75.02

Price Performance

Historical Comparison
BXP
ICLR

About BXP Boston Properties Inc.

BXP owns 179 properties consisting of approximately 52.6 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: